New tests for cervical cancer screening

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The Papanicolaou (Pap) smear has been used to screen women for cervical cancer since 1940. Recently, a number of new technologies have been developed to improve the detection of cervical cancer and its precursors. However, there is substantial controversy about whether the new tests offer meaningful advantages over the conventional Pap smear. Ideally, these new tests will increase the early detection of meaningful Pap smear abnormalities, reduce the number of unsatisfactory smears and provide fewer ambiguous results. It is also hoped that these new screening methods will not increase the number of false-positive results, but will improve the productivity of cytology laboratories without substantially increasing costs. The new tests include liquid-based/thin-layer preparations to improve the quality and adequacy of the Pap smear; computer-assisted screening methods to improve Pap smear interpretation; and new-generation human papillomavirus testing methods that may be useful in triaging patients with atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions. Evidence on these new tests is reviewed and the advantages and disadvantages of their use are discussed.

Original languageEnglish (US)
Pages (from-to)780-786
Number of pages7
JournalAmerican Family Physician
Volume64
Issue number5
StatePublished - Sep 1 2001

Fingerprint

Papanicolaou Test
Early Detection of Cancer
Uterine Cervical Neoplasms
Cell Biology
Technology
Costs and Cost Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

New tests for cervical cancer screening. / Nuovo, James; Melnikow, Joy; Howell, Lydia P.

In: American Family Physician, Vol. 64, No. 5, 01.09.2001, p. 780-786.

Research output: Contribution to journalArticle

@article{c4634795dba846b2a0eddf3d1d4d7b71,
title = "New tests for cervical cancer screening",
abstract = "The Papanicolaou (Pap) smear has been used to screen women for cervical cancer since 1940. Recently, a number of new technologies have been developed to improve the detection of cervical cancer and its precursors. However, there is substantial controversy about whether the new tests offer meaningful advantages over the conventional Pap smear. Ideally, these new tests will increase the early detection of meaningful Pap smear abnormalities, reduce the number of unsatisfactory smears and provide fewer ambiguous results. It is also hoped that these new screening methods will not increase the number of false-positive results, but will improve the productivity of cytology laboratories without substantially increasing costs. The new tests include liquid-based/thin-layer preparations to improve the quality and adequacy of the Pap smear; computer-assisted screening methods to improve Pap smear interpretation; and new-generation human papillomavirus testing methods that may be useful in triaging patients with atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions. Evidence on these new tests is reviewed and the advantages and disadvantages of their use are discussed.",
author = "James Nuovo and Joy Melnikow and Howell, {Lydia P}",
year = "2001",
month = "9",
day = "1",
language = "English (US)",
volume = "64",
pages = "780--786",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "5",

}

TY - JOUR

T1 - New tests for cervical cancer screening

AU - Nuovo, James

AU - Melnikow, Joy

AU - Howell, Lydia P

PY - 2001/9/1

Y1 - 2001/9/1

N2 - The Papanicolaou (Pap) smear has been used to screen women for cervical cancer since 1940. Recently, a number of new technologies have been developed to improve the detection of cervical cancer and its precursors. However, there is substantial controversy about whether the new tests offer meaningful advantages over the conventional Pap smear. Ideally, these new tests will increase the early detection of meaningful Pap smear abnormalities, reduce the number of unsatisfactory smears and provide fewer ambiguous results. It is also hoped that these new screening methods will not increase the number of false-positive results, but will improve the productivity of cytology laboratories without substantially increasing costs. The new tests include liquid-based/thin-layer preparations to improve the quality and adequacy of the Pap smear; computer-assisted screening methods to improve Pap smear interpretation; and new-generation human papillomavirus testing methods that may be useful in triaging patients with atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions. Evidence on these new tests is reviewed and the advantages and disadvantages of their use are discussed.

AB - The Papanicolaou (Pap) smear has been used to screen women for cervical cancer since 1940. Recently, a number of new technologies have been developed to improve the detection of cervical cancer and its precursors. However, there is substantial controversy about whether the new tests offer meaningful advantages over the conventional Pap smear. Ideally, these new tests will increase the early detection of meaningful Pap smear abnormalities, reduce the number of unsatisfactory smears and provide fewer ambiguous results. It is also hoped that these new screening methods will not increase the number of false-positive results, but will improve the productivity of cytology laboratories without substantially increasing costs. The new tests include liquid-based/thin-layer preparations to improve the quality and adequacy of the Pap smear; computer-assisted screening methods to improve Pap smear interpretation; and new-generation human papillomavirus testing methods that may be useful in triaging patients with atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions. Evidence on these new tests is reviewed and the advantages and disadvantages of their use are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0035448185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035448185&partnerID=8YFLogxK

M3 - Article

VL - 64

SP - 780

EP - 786

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 5

ER -